Go Pro

Autonomix Medical (AMIX) Competitors

Autonomix Medical logo
$4.33 -0.04 (-0.92%)
Closing price 09/14/2026 04:00 PM Eastern
Extended Trading
$4.32 -0.01 (-0.35%)
As of 05:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AMIX vs. HSCS, NMTC, TMDIF, ADGM, and ICU

Should you buy Autonomix Medical stock or one of its competitors? Autonomix Medical's main competitors and comparable companies include HeartSciences (HSCS), NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), Adagio Medical (ADGM), and SeaStar Medical (ICU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Autonomix Medical compare to HeartSciences?

Autonomix Medical (NASDAQ:AMIX) and HeartSciences (NASDAQ:HSCS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 4.9% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Autonomix Medical currently has a consensus target price of $42.00, suggesting a potential upside of 869.98%. HeartSciences has a consensus target price of $8.00, suggesting a potential upside of 125.99%. Given Autonomix Medical's higher possible upside, analysts clearly believe Autonomix Medical is more favorable than HeartSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
HeartSciences
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

HeartSciences is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A
HeartSciencesN/AN/A-$9.14M-$3.94N/A

Autonomix Medical has a beta of -1, meaning that its share price is 200% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

In the previous week, HeartSciences had 1 more articles in the media than Autonomix Medical. MarketBeat recorded 4 mentions for HeartSciences and 3 mentions for Autonomix Medical. Autonomix Medical's average media sentiment score of 0.84 beat HeartSciences' score of -0.63 indicating that Autonomix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
HeartSciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

Autonomix Medical's return on equity of -267.73% beat HeartSciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -267.73% -216.75%
HeartSciences N/A -358.60%-144.82%

Summary

HeartSciences beats Autonomix Medical on 6 of the 11 factors compared between the two stocks.

How does Autonomix Medical compare to NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by insiders. Comparatively, 6.2% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

NeuroOne Medical Technologies has higher revenue and earnings than Autonomix Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroOne Medical Technologies$12.10M1.13-$3.61M-$0.95N/A
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A

NeuroOne Medical Technologies currently has a consensus price target of $7.33, indicating a potential upside of 388.89%. Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 869.98%. Given Autonomix Medical's higher possible upside, analysts clearly believe Autonomix Medical is more favorable than NeuroOne Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroOne Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, NeuroOne Medical Technologies had 3 more articles in the media than Autonomix Medical. MarketBeat recorded 6 mentions for NeuroOne Medical Technologies and 3 mentions for Autonomix Medical. NeuroOne Medical Technologies' average media sentiment score of 0.95 beat Autonomix Medical's score of 0.84 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeuroOne Medical Technologies
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Autonomix Medical has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -71.50%. NeuroOne Medical Technologies' return on equity of -128.12% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroOne Medical Technologies-71.50% -128.12% -86.34%
Autonomix Medical N/A -267.73%-216.75%

NeuroOne Medical Technologies has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1, suggesting that its share price is 200% less volatile than the broader market.

Summary

NeuroOne Medical Technologies beats Autonomix Medical on 12 of the 15 factors compared between the two stocks.

How does Autonomix Medical compare to Titan Medical?

Autonomix Medical (NASDAQ:AMIX) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Autonomix Medical presently has a consensus price target of $42.00, indicating a potential upside of 869.98%. Given Autonomix Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Autonomix Medical is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Autonomix Medical has a beta of -1, indicating that its stock price is 200% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

In the previous week, Autonomix Medical had 3 more articles in the media than Titan Medical. MarketBeat recorded 3 mentions for Autonomix Medical and 0 mentions for Titan Medical. Autonomix Medical's average media sentiment score of 0.84 beat Titan Medical's score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the media.

Company Overall Sentiment
Autonomix Medical Positive
Titan Medical Neutral

Titan Medical's return on equity of -82.31% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -267.73% -216.75%
Titan Medical N/A -82.31%-51.47%

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Titan Medical has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A
Titan Medical$17.63M0.78$6.95M$0.052.41

Summary

Autonomix Medical and Titan Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does Autonomix Medical compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

In the previous week, Autonomix Medical had 2 more articles in the media than Adagio Medical. MarketBeat recorded 3 mentions for Autonomix Medical and 1 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 1.87 beat Autonomix Medical's score of 0.84 indicating that Adagio Medical is being referred to more favorably in the media.

Company Overall Sentiment
Adagio Medical Very Positive
Autonomix Medical Positive

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by company insiders. Comparatively, 6.2% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Adagio Medical presently has a consensus target price of $3.50, suggesting a potential upside of 676.91%. Autonomix Medical has a consensus target price of $42.00, suggesting a potential upside of 869.98%. Given Autonomix Medical's higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Adagio Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Adagio Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio MedicalN/AN/A-$25.08M-$1.48N/A
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A

Autonomix Medical's return on equity of -267.73% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A -661.85% -73.35%
Autonomix Medical N/A -267.73%-216.75%

Adagio Medical has a beta of -0.09, suggesting that its stock price is 109% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1, suggesting that its stock price is 200% less volatile than the broader market.

Summary

Adagio Medical beats Autonomix Medical on 8 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to SeaStar Medical?

Autonomix Medical (NASDAQ:AMIX) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Autonomix Medical presently has a consensus target price of $42.00, suggesting a potential upside of 869.98%. SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 160.59%. Given Autonomix Medical's higher probable upside, equities analysts plainly believe Autonomix Medical is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

SeaStar Medical has higher revenue and earnings than Autonomix Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A
SeaStar Medical$1.23M11.01-$12.15M-$3.91N/A

In the previous week, Autonomix Medical had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 3 mentions for Autonomix Medical and 2 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.93 beat Autonomix Medical's score of 0.84 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Autonomix Medical has a net margin of 0.00% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -267.73% -216.75%
SeaStar Medical -795.51%-162.75%-109.89%

Autonomix Medical has a beta of -1, suggesting that its share price is 200% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, suggesting that its share price is 205% less volatile than the broader market.

Summary

Autonomix Medical beats SeaStar Medical on 7 of the 13 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMIX vs. The Competition

MetricAutonomix MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$4.24M$5.42B$7.16B$14.30B
Dividend YieldN/A1.80%2.57%11.71%
P/E Ratio-0.1025.11273.3025.37
Price / SalesN/A71.75647.3987.55
Price / CashN/A33.0328.4234.96
Price / Book0.406.0310.486.24
Net Income-$16.72M$150.14M$3.49B$358.08M
7 Day Performance-5.46%-1.33%-1.11%-0.70%
1 Month Performance-36.79%-3.22%0.60%-2.76%
1 Year Performance-81.59%9.62%20.20%6.72%

Autonomix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMIX
Autonomix Medical
2.5949 of 5 stars
$4.33
-0.9%
$42.00
+870.0%
-81.4%$4.24MN/AN/A1
HSCS
HeartSciences
1.8891 of 5 stars
$4.12
+1.0%
$8.00
+94.2%
+17.6%$15.91MN/AN/A10
NMTC
NeuroOne Medical Technologies
3.5941 of 5 stars
$1.66
-1.8%
$7.33
+341.8%
-71.9%$15.39M$12.10MN/A20
TMDIF
Titan Medical
N/A$0.13
+2.0%
N/A-66.8%$14.98M$17.63MN/A50
ADGM
Adagio Medical
3.1739 of 5 stars
$0.61
-0.4%
$3.50
+478.5%
-73.8%$13.49M$600KN/A87

Related Companies and Tools


This page (NASDAQ:AMIX) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners